Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
Abstract The kidney flushes out toxic substances and metabolic waste products, and homeostasis is maintained owing to the kidney efforts. Unfortunately, kidney disease is one of the illnesses with a poor prognosis and a high death rate. The current investigation was set out to assess erythropoietin...
Main Authors: | Marawan A. Elbaset, Bassim M. S. A. Mohamed, Shaimaa A. Gad, Sherif M. Afifi, Tuba Esatbeyoglu, Sahar S. Abdelrahman, Hany M. Fayed |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-42210-1 |
Similar Items
-
Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
by: Marawan A. Elbaset, et al.
Published: (2024-01-01) -
Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
by: Marwan A. ElBaset, et al.
Published: (2022-10-01) -
Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
by: Omima S. Mohammed, et al.
Published: (2023-11-01) -
Chemical Profile of <i>Cyperus laevigatus</i> and Its Protective Effects against Thioacetamide-Induced Hepatorenal Toxicity in Rats
by: Iriny M. Ayoub, et al.
Published: (2022-10-01) -
Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathways
by: Rehab Fawzy Abdel-Rahman, et al.
Published: (2023-04-01)